Skip to main content
SH

Salma Health

Salma Health provides an integrated brain‑health platform that combines advanced diagnostics, evidence‑based psychotherapy, medication management, and FDA‑cleared neuromodulation therapies such as TMS, SAINT® accelerated TMS, and Spravato® (esketamine).

San Mateo, United StatesFounded 2025762K+ followers
Updated 2 months ago

Funding

Funding not disclosed

Funding rounds are not available yet.

Founders

Founder details are not available yet.

Product

Problem

Patients with mood, anxiety, trauma‑related, cognitive and brain injury conditions often face fragmented care, long wait times, and limited access to advanced neuromodulation and precision diagnostics, which can delay effective treatment and reduce outcomes.

Solution

Salma Health delivers an integrated brain‑health platform that combines advanced diagnostics, evidence‑based psychotherapy, medication management, and FDA‑cleared neuromodulation therapies such as Transcranial Magnetic Stimulation (TMS), SAINT® accelerated TMS, and Spravato® (esketamine). The care pathway begins with a comprehensive intake that maps medical, psychiatric and neurological factors, then generates a personalized treatment plan that evolves through continuous progress monitoring. Services are coordinated across virtual and in‑clinic settings, allowing rapid insurance verification, same‑day treatment matching, and ongoing adjustments. Patients receive a unified dashboard for symptom tracking, while clinicians access shared records that link diagnostics, therapy notes and neuromodulation parameters, ensuring seamless, data‑driven care.

Target Audience

Primary users are adults experiencing depression, anxiety, PTSD, OCD, ADHD, traumatic brain injury, migraine or other neurological and mental‑health conditions who seek coordinated, evidence‑based treatment; the service also supports clinicians and health systems looking for an integrated brain‑health delivery model.

Features

  • Comprehensive intake that integrates psychological, medical and neuroimaging data to create a 360° diagnostic profile
  • FDA‑cleared neuromodulation options: standard TMS, Stanford Accelerated Intelligent Neuromodulation Therapy (SAINT®) and Spravato® (esketamine) with MRI‑guided targeting
  • Virtual Intensive Outpatient Program (IOP) delivering group and individual therapy, medication management and skill‑building sessions online
  • Continuous outcome tracking via a patient portal that feeds real‑time data back to the care team for treatment adjustments
  • Coordination of multiple modalities (therapy, medication, neuromodulation, lifestyle support) within a single care team
  • Insurance verification and prior‑authorization support to streamline access to covered services
  • Participation in clinical trials and research registries at no cost to patients, providing early access to emerging therapies
This profile is AI-generated and may contain inaccuracies.